Jennifer Simpson | executive |
Susan Horvath | executive |
Jonathan Aschoff | analyst |
Joshua Korsen | analyst |
Good afternoon, everyone, and welcome to the Panbela Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, James Carbonara, Investor Relations. James, over to you.
Thank you, operator.